Evidence-Based, Data-Driven Patient Recruitment and Retention

Venue: Hyatt Regency Bethesda

Location: Bethesda, Maryland, United States

Event Date/Time: Oct 22, 2013 / 12:15 pm - (EST) End Date/Time: Oct 23, 2013 / 4:30 pm - (EST)
Early Registration Date: Sep 20, 2013
Report as Spam


The average cost of clinical trials has risen to nearly 60% of total development costs. Patient recruitment delays and a low retention rate are key factors in this increase of costs, leading to a delay in product launch and a subsequent reduction in product exclusivity. Patient recruitment, if not adequately planned and managed, can extend the development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential to obtaining the best data sets for analysis and subsequent filings. In order to optimize both recruitment and retention there needs to be a plan and performance management approach based on evidence, data and a set of tools you know will work. This conference is intended to cover the latest differentiators in recruitment and retention; the newest opportunities in online social networks, EMRs and Big Data to support decision making; evidence-based identification and selection of investigators; recruitment of special populations; and lessons learned from various therapeutic areas. "Evidence-Based, Data-Driven Patient Recruitment and Retention" will provide a comprehensive real-world perspective on this challenging arena, with key takeaways you can implement right away to ensure the best results.


1 Bethesda Metro Ctr
United States

Conference Speakers

  • Bill Gwinn, MBA, Vice President, Clinical Informatics Solutions, OptumInsight
  • Christine Dehner, Senior Clinical Trial Manager, Clinical Ops, Seattle Genetics, Inc.
  • Adam Chasse, COO, RxTrials
  • Robin DeMent, Vice President, R&D-IT, Medicines Development Capabilities, GlaxoSmithKline
  • Tania Bojanowski, Director, Development Operations & Strategic Planning, sanofi oncology
  • Mary Jo Lamberti, Ph.D., Senior Project Manager, Tufts CSDD, Tufts University
  • Elizabeth Mascherino, Associate Director, Clinical Operations, Shire Pharmaceuticals
  • Amy Loescher, Director, Clinical Trials Lead, Janssen R&D
  • Gerson Peltz, M.D., Medical Director, Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb
  • Lynne Nguyen, Director, Population & Community Core, Center for Community-Engaged Translational Research, MD Anderson Cancer Center
  • Rebecca Budd, MBA, Managing Director, Navita Clinical Strategy Group
  • Chris Conklin, Associate Director, Clinical Research, Global Trial Optimization, Merck
  • Damon Michaels, Director, Clinical Trials Research, Vanderbilt University Medical Center
  • Janet Flisak, Director, Clinical Research, Johnson & Johnson
  • Greg Biggers, Reg4ALL / Genetic Alliance
  • Nariman Nasser, Senior Director, Recruitment & Implementation Core, Clinical Research Services, Clinical & Translational Science Institute, University of California San Francisco